SCHEMBL30948151

SCHEMBL30948151

ClCc1nnc(-c2ccccc2Cl)s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.59
HPGD P15428 5/20 0.59
KDM4E B2RXH2 4/20 0.59
HSD17B10 Q99714 4/20 0.59
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA3 P07451 1/20 0.51
CA6 P23280 1/20 0.51
CA5A P35218 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
CA5B Q9Y2D0 1/20 0.51
GUSB P08236 1/20 0.48
NPC1 O15118 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
TP53 P04637 2/20 0.47
PKM P14618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2441042 0.84 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10TDP1
SCHEMBL18611243 0.84 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10TDP1
SCHEMBL30948356 0.82 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL10612164 0.81 ALDH1A1 (0.38) ALDH1A1HPGDKDM4EHSD17B10CA12
SCHEMBL9848132 0.77 ALDH1A1 (0.67) ALDH1A1HPGDKDM4EHSD17B10TDP1
SCHEMBL20864389 0.76 HDAC6 (0.48) ALDH1A1CA1CA2CA5ACA5B
SCHEMBL2447703 0.75 PTPN11 (0.45) ALDH1A1HPGDKDM4EHSD17B10CA12
SCHEMBL11326692 0.74 KDM4E (1.00) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL21065048 0.74 ALDH1A1 (0.62) ALDH1A1HPGDKDM4EHSD17B10CA12
SCHEMBL970693 0.74 ALDH1A1 (0.62) ALDH1A1HPGDKDM4EHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240246937-A1 IL4I1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC (US) 2024-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246937-A1 IL4I1 INHIBITORS AND METHODS OF USE IL4I1, IL4, IL2 ALDH1A1 283/4885HPGD 2021/4885KDM4E 1134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.